Restoring Life’s Potential

by enabling the nervous system to repair itself after neurologic
trauma and disease

Recent Press Releases

View All

NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams

February 12, 2026

NervGen announced that Bill Adams will retire as Chief Financial Officer. The Company has engaged a leading executive search firm to identify a successor.  

Read More ›

NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium

February 11, 2026

NervGen announced the Company will present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium, which is being held February 15-17, 2026, in Washington, DC.   

READ MORE ›

NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury

February 09, 2026

NervGen announced its Board of Directors has unanimously appointed Adam Rogers, MD, as President and Chief Executive Officer, effective immediately. 

Read More ›

Phase 1b/2a CONNECT SCI Study for 
Individuals with Spinal Cord Injury

VIEW INFORMATION

For information regarding recruitment, the call center phone number is +1 (855) 559-6902. 

View NervGen’s Origin Story Video

VIEW VIDEO

Stay Connected

Subscribe to our mailing list to stay up to date